26 / 88
26
Scientific Programme /
Sunday, 18 June 2017
WFSBP 2017
SUN
T43: SCHIZOPHRENIA: BASIC/ CLINICAL
S-11
SYMPOSIUM
14:30–16:00
Congress Hall A 3
Abnormal neurogenesis in schizophrenia
Chair:
Dragos Inta, Germany
Co-Chair: Guo-Li Ming, USA
001
Modeling predisposition to schizophrenia using
hiPSCs
Kristen Brennand, USA
002
Neurogenesis and psychiatric neurodevelopmental
disorders
Guo-Li Ming, USA
003
Precise activation of the Reelin pathway controls
dendritic maturation, synapse formation and glial
ensheathment of adult-generated granule cells
Eduardo Soriano, Spain
004
Adult neurogenesis in the striatum: Effect of
psychiatric treatment
Dragos Inta, Germany
T6: BIPOLAR DISORDERS: BASIC/ CLINICAL
S-12
SYMPOSIUM
14:30–16:00
B3 M1-M2
New approaches into diagnosis and treatment of
psychotic Bipolar Disorder (BP)
Chair:
Carlo Altamura, Italy
Co-Chair: Allan Young, United Kingdom
001
Neuroimaging aspects of psychotic Bipolar
Disorder (BP)
Paolo Brambilla, Italy
002
Candidate biomarkers for psychotic Bipolar
Disorder (BP): The role of neuroinflammation and
hormones
Massimiliano Buoli, Italy
003
The role of dopamine in psychotic bipolar disorder
and treatment implications
Oliver Howes, United Kingdom
T10: DEMENTIA: BASIC/ CLINICAL
S-13
SYMPOSIUM
16:30–18:00
B3 M1-M2
Biomarkers for early diagnosis of Alzheimer's
Disease (AD) and other neurodegenerating diseases:
Advantages and limitations
Chair:
Piotr Lewczuk, Germany
Co-Chair: Henrik Zetterberg, Sweden
001
New developments in the biomarkers for
Alzheimer's Disease (AD)
Kaj Blennow, Sweden
002
Amyloid beta 42 / 40 Ratio in diagnosis of AD:
Do we need it?
Piotr Lewczuk, Germany
003
Sensitive technologies for blood biomarkers in
neurodegeneration
Henrik Zetterberg, Sweden
004
Current diagnostic approaches in frontotemporal
lobar degeneration
Markus Otto, Germany
OPENING SESSION
18:00–19:00
Auditorium 10+11+12
Opening Ceremony
Chair:
Masatoshi Takeda, Japan
001
The microbiome-gut-brain axis: A key regulator
of brain & behaviour across the lifespan
John F. Cryan, Ireland
Please see page 15.